Clinical trial
A Pilot Study of Exendin-4 in Alzheimer s Disease
NCT01255163 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Exendin-4 in Alzheimer s Disease
- Lead sponsor
- National Institute on Aging (NIA)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 21, 2010
- Completion date
- November 18, 2016
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, mild cognitive impairment